IPHARMA IZEMPIC COMPOUND PEPTIDE PEN 5MG 2ML
R1,350.00
Ozempic® is an injectable medication containing Semaglutide, a clinically proven GLP-1 receptor agonist originally developed to help manage type 2 diabetes. It works by mimicking the natural GLP-1 hormone which regulates appetite, slows digestion and helps control blood sugar levels — making it highly effective for both weight loss and metabolic balance.
Description
How It Works
Semaglutide acts on GLP-1 receptors in the body to:
Reduce hunger and calorie intake
Slow gastric emptying to increase fullness
Stimulate insulin secretion when blood sugar is high
Lower glucose production by the liver
This combination of effects helps promote steady, sustainable weight loss while improving overall metabolic health.
Product Description
Form: Prefilled, single-use pen containing a clear liquid solution
Active Ingredient: Semaglutide
Administration: Subcutaneous injection (under the skin)
Recommended injection sites:
Abdomen (stomach area)
Upper thigh
Back of upper arm
If you also inject insulin, you may use the same body region — but never the same injection spot — to prevent irritation.
Do not mix Ozempic with insulin in the same syringe.
Usage Instructions:
Inject once weekly, on the same day each week
Can be taken any time of day, with or without food
Rotate injection sites to avoid skin irritation
Dosage Guide
10 Units = 0.125mg Semaglutide
| Week | Dose (mg) | Units | Notes |
|---|---|---|---|
| 1 | 0.25mg | 20 units | Initiation phase |
| 2 | 0.50mg | 40 units | Titration |
| 3 | 0.50mg | 40 units | Continue dose |
| 4 | 0.50mg | 40 units | Maintain tolerance |
| 5 | 0.75mg | 60 units | Begin stronger response |
| 6+ | 0.75–1.0mg | 60–80 units | Ongoing maintenance |
Increase dosage gradually to minimize nausea or digestive discomfort.